Prevalence of major depression one year after predictive testing for Huntington's disease

Genetic Testing

Volumn 8, Issue 2, 2004, Pages 114-119

  Codori, Ann Marie ^a,b   Slavney, Phillip R ^a   Rosenblatt, Adam ^a   Brandt, Jason ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; EMOTIONAL STRESS; FEMALE; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREVALENCE;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; DISCLOSURE; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 4143108963     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2004.8.114     Document Type: Article

References (30)

1. ALMQVIST, E.W., BLOCH, M., BRINKMAN, R., CRAUFURD, D., and HAYDEN, M.R. (1999). A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am. J. Hum. Genet. 64, 1293-1304.
2. ALMQVIST, E.W., BRINKMAN, R.R., WIGGINS, S., and HAYDEN, M.R. (2003). The Canadian Collaborative Study of Predictive Testing. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin. Genet. 64, 300-309.
3. AMERICAN PSYCHIATRIC ASSOCIATION. (1994). Diagnostic and statistical manual of mental disorders (DSM) - IV. American Psychiatric Association, Washington, D.C.
4. AMERICAN PSYCHIATRIC ASSOCIATION. (1985). Diagnostic and statistical manual of mental disorders-III. American Psychiatric Association, Washington, D.C.
5. BECK, A.T., STEER, R.A., and GARBIN, M.G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin. Psych. Rev. 8, 77-100.
6. BLOCH, M., ADAM, S., WIGGINS, S., HUGGINS, M., and HAYDEN, M.R. (1992). Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am. J. Med. Genet. 42, 499-507.
7. BRANDT, J., QUAID, K.A., FOLSTEIN, S.E., GARBER, P., MAESTRI, N.E., ABBOTT, M.H., et al. (1989). Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. J. Am. Med. Assn. 261, 3108-3114.
8. CODORI, A.M., and BRANDT, J. (1994). Psychological costs and benefits of predictive testing for Huntington's disease. Am. J. Med. Genet. 54, 174-184.
9. CODORI, A.M., SLAVNEY, P.R., YOUNG, C., MIGLIORETTI, D.L., and BRANDT, J. (1997). Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol. 16, 36-50.
10. DECRUYENAERE, M., EVERS-KIEBOOMS, G., CLOOSTERMANS, T., BOOGAERTS, A., DEMYTTENAERE, K., DOM, R., and FRYNS, J.P. (2003). Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur. J. Hum. Genet. 11, 30-38.
11. ENDICOTT, J., and SPITZER, R.L. (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatr. 35, 837-844.
12. ENDICOTT, J., and SPITZER, R.L. (1979). Use of the research diagnostic criteria and the schedule for affective disorders and schizophrenia to study affective disorders. Am. J. Psychiatr. 136, 52-56.
13. ENDICOTT, J., SPITZER, R.L., FLEISS, J.L., and COHEN, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatr. 33, 766-771.
14. FARRER, L. (1987). Suicide and presymptomatic testing in Huntington disease. Am. J. Med. Genet. 25, 577-588.
15. FOLSTEIN, S.E. (1989). Huntington's disease: a disorder of families. Johns Hopkins University Press, Baltimore, MD.
16. HARPER, P.S. (ed). (1996). Huntington's disease, 2nd ed. Saunders, Philadelphia, PA.
17. HUGGINS, M., BLOCH, M., WIGGINS, S., ADAM, S., SUCHOWERSKY, O., TREW, M., et al. (1992). Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am. J. Med. Genet. 42, 508-515.
18. HUNTINGTON'S DISEASE COLLABORATIVE RESEARCH GROUP. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
19. KESSLER, S. (1987a). Psychiatric implications of presymptomatic testing for Huntington's disease. Am. J. Orthopsychiatr. 57, 212-219.
20. KESSLER, S. (1987b). The dilemma of suicide and Huntington disease. Am. J. Med. Genet. 26, 315-320.
21. LUBORSKY, L. (1962). Clinician's judgments of mental health. Arch. Gen. Psychiatr. 7, 407-417.
22. MEISSEN, G.J., and BERCHEK, R.L. (1987). Intended use of predictive testing by those at risk for Huntington disease. Am. J. Med. Genet. 26, 283-293.
23. MEISSEN, G.J., MYERS, R.H., MASTROMAURO, C.A., KOROSHETZ, W.J., KLINGER, K.W., FARRER, L.A., et al. (1988). Predictive testing for Huntington's disease with use of a linked DNA marker. N. Engl. J. Med. 318, 535-542.
24. ROBINS, L.N., HELZER, J.E., RATCLIFF, K.S., and SEYFRIED, W. (1982). Validity of the diagnostic interview schedule, version 11: DSM-III diagnoses. Psychol. Med. 12, 855-870.
25. SPITZER, R.L., WILLIAMS, J.B., GIBBON, M., and FIRST, M.B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatr. 49, 624-629.
26. SPITZER, R.L., WILLIAMS, J.B., KROENKE, K., LINZER, M., DEGRUY, F.V., III, HAHN, S.R., et al. (1994). Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. J. Am. Med. Assn. 272, 1749-1756.
27. TIBBEN, A., FRETS, P.G., VAN DE KAMP, J.J., NIERMEIJER, M.F., VEGTERVAN, D.V., ROOS, R.A. et al. (1993). On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am. J. Med. Genet. 48, 103-111.
28. TIBBEN, A., DUIVENVOORDEN, H.J., NIERMEIJER, M.F., VEGTER-VAN DER VLIS, M., ROOS, R.A., and VERHAGE, F. (1994). Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom. Med. 56, 526-532.
29. WEISSMAN, M.M., BLAND, R.C., CANINO, G.J., FARAVELLI, C., GREENWALD, S., HWU, H.G., et al. (1996). Cross-national epidemiology of major depression and bipolar disorder. J. Am. Med. Assn. 276, 293-299.
30. WIGGINS, S., WHYTE, P., HUGGINS, M., ADAM, S., THEILMANN, J., BLOCH, M., et al. (1992). The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N. Engl. J. Med. 327, 1401-1405.